Compare QNCX & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | ACR |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 148.3M |
| IPO Year | 2019 | N/A |
| Metric | QNCX | ACR |
|---|---|---|
| Price | $3.06 | $19.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $7.67 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 934.0K | 18.8K |
| Earning Date | 11-12-2025 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.65 |
| EPS | N/A | ★ 0.95 |
| Revenue | N/A | ★ $88,952,000.00 |
| Revenue This Year | N/A | $3.67 |
| Revenue Next Year | N/A | $1.87 |
| P/E Ratio | ★ N/A | $21.10 |
| Revenue Growth | N/A | ★ 14.87 |
| 52 Week Low | $0.72 | $15.64 |
| 52 Week High | $4.55 | $24.61 |
| Indicator | QNCX | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 47.31 | 38.00 |
| Support Level | $2.85 | $19.85 |
| Resistance Level | $3.72 | $20.82 |
| Average True Range (ATR) | 0.31 | 0.51 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 41.38 | 20.00 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.